The bill expands federally funded preventive services and strengthens follow-up for low-income women—improving early detection and public-health monitoring—while requiring $250M in federal spending and introducing potential variability in access and administrative burdens for providers.
Low-income women and uninsured individuals will gain access to additional preventive services (e.g., blood pressure and cholesterol screening) and stronger referral/follow-up requirements, increasing the likelihood that abnormal results lead to timely medical treatment.
The bill provides $250 million in federal funding over five years to expand preventive services for underserved populations, which can lower future healthcare costs by identifying and treating conditions earlier.
Grant funding supports evaluation and surveillance of services, improving program effectiveness and public-health monitoring for state governments and health systems.
Who gets services may vary by Secretary-specified eligibility rules and designee approvals, creating potential uneven access across states and leaving some eligible people without consistent coverage.
Grant recipients (e.g., hospitals and state programs) will face increased administrative and reporting burdens to meet referral, follow-up, and evaluation requirements, which could strain providers and reduce program efficiency.
Taxpayers will fund the $250 million appropriation, representing a fiscal cost that could compete with other federal priorities.
Based on analysis of 2 sections of legislative text.
Authorizes CDC supplemental grants to expand preventive heart-health services for low-income women and funds $250M for FY2027–2031.
Official title: To amend the Public Health Service Act to reauthorize the WISEWOMAN program.
Introduced February 9, 2026 by Joyce Beatty · Last progress February 9, 2026
Authorizes the CDC to award supplemental grants to existing breast and cervical cancer screening program grantees and other approved providers to add preventive heart-health services for low-income women, including blood pressure and cholesterol screening, health education, referrals, follow-up, and program evaluation. Provides authorization of $250 million for fiscal years 2027–2031 to carry out these supplemental grants. Defines eligible women as those served under the existing screening program and other low-income women the Secretary identifies, and allows services to be delivered by current screening program providers or other Secretary-approved designees. Requires monitoring or surveillance to evaluate the activities funded by the grants.